Arranz Alicia, Ripoll Jorge
Department of Cell Biology and Immunology, Center for Molecular Biology "Severo Ochoa", Spanish National Research Council , Madrid, Spain.
Department of Bioengineering and Aerospace Engineering, Universidad Carlos III of Madrid , Madrid, Spain ; Experimental Medicine and Surgery Unit, Instituto de Investigación Sanitaria del Hospital Gregorio Marañón , Madrid, Spain.
Front Pharmacol. 2015 Sep 11;6:189. doi: 10.3389/fphar.2015.00189. eCollection 2015.
Imaging approaches are an essential tool for following up over time representative parameters of in vivo models, providing useful information in pharmacological studies. Main advantages of optical imaging approaches compared to other imaging methods are their safety, straight-forward use and cost-effectiveness. A main drawback, however, is having to deal with the presence of high scattering and high absorption in living tissues. Depending on how these issues are addressed, three different modalities can be differentiated: planar imaging (including fluorescence and bioluminescence in vivo imaging), optical tomography, and optoacoustic approaches. In this review we describe the latest advances in optical in vivo imaging with pharmacological applications, with special focus on the development of new optical imaging probes in order to overcome the strong absorption introduced by different tissue components, especially hemoglobin, and the development of multimodal imaging systems in order to overcome the resolution limitations imposed by scattering.
成像方法是长期跟踪体内模型代表性参数的重要工具,可为药理学研究提供有用信息。与其他成像方法相比,光学成像方法的主要优点是其安全性、使用简便和成本效益。然而,一个主要缺点是必须应对活组织中高散射和高吸收的存在。根据这些问题的解决方式,可以区分出三种不同的模式:平面成像(包括体内荧光和生物发光成像)、光学断层扫描和光声方法。在本综述中,我们描述了光学体内成像在药理学应用方面的最新进展,特别关注新型光学成像探针的开发,以克服不同组织成分(尤其是血红蛋白)引入的强吸收,以及多模态成像系统的开发,以克服散射带来的分辨率限制。